Marinus (MRNS)

Marinus (MRNS) Stock Price & Analysis


MRNS Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.47 - $10.94
Previous Close$6.79
Average Volume (3M)423.77K
Market Cap
Enterprise Value$204.59M
Total Cash (Recent Filing)$240.55M
Total Debt (Recent Filing)$103.87M
Price to Earnings (P/E)-14.8
May 03, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.46
Shares Outstanding49,617,697
10 Day Avg. Volume482,765
30 Day Avg. Volume423,774
Standard Deviation0.26
Financial Highlights & Ratios
Price to Book (P/B)4.66
Price to Sales (P/S)19.83
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-3.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.03
Enterprise Value/Gross Profit8.14
Enterprise Value/Ebitda-38.33
Price Target Upside233.28% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Marinus’s price range in the past 12 months?
Marinus lowest stock price was $3.46 and its highest was $10.94 in the past 12 months.
    What is Marinus’s market cap?
    Currently, no data Available
    When is Marinus’s upcoming earnings report date?
    Marinus’s upcoming earnings report date is May 03, 2023 which is in 44 days.
      How were Marinus’s earnings last quarter?
      Marinus released its earnings results on Mar 07, 2023. The company reported -$0.76 earnings per share for the quarter, missing the consensus estimate of -$0.62 by -$0.14.
        Is Marinus overvalued?
        According to Wall Street analysts Marinus’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Marinus pay dividends?
          Marinus does not currently pay dividends.
          What is Marinus’s EPS estimate?
          Marinus’s EPS estimate is -$0.73.
            How many shares outstanding does Marinus have?
            Marinus has 49,665,115 shares outstanding.
              What happened to Marinus’s price movement after its last earnings report?
              Marinus reported an EPS of -$0.76 in its last earnings report, missing expectations of -$0.62. Following the earnings report the stock price went up 5.398%.
                Which hedge fund is a major shareholder of Marinus?
                Among the largest hedge funds holding Marinus’s share is Woodline Partners LP. It holds Marinus’s shares valued at 6M.


                  Marinus Stock Smart Score

                  The Marinus stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded by Geoffrey E. Chaiken, Harry H. Penner Jr., Vincent A. Pieribone and Kenneth R. Shaw on August 14, 2003 and is headquartered in Radnor, PA.


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Rain Therapeutics
                  Theseus Pharmaceuticals
                  Terns Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis